Scientific Directorate
Roberto Orecchia has not added Biography.
If you are Roberto Orecchia and would like to personalize this page please email our Author Liaison for assistance.
Phase II trial of vinorelbine, cisplatin and continuous infusion of 5-fluorouracil followed by hyperfractionated radiotherapy in locally advanced head and neck cancer.
Oncology , 2002 | Pubmed ID: 12239445
Intraoperative radiation therapy with electrons (ELIOT) in early-stage breast cancer.
Breast (Edinburgh, Scotland) Dec, 2003 | Pubmed ID: 14659125
Clinical and research validity of hadrontherapy with ion beams.
Critical reviews in oncology/hematology Aug, 2004 | Pubmed ID: 15276173
Intraoperative electrons.
Seminars in radiation oncology Apr, 2005 | Pubmed ID: 15809932
Intraoperative electron beam radiotherapy (ELIOT) to the breast: a need for a quality assurance programme.
Breast (Edinburgh, Scotland) Dec, 2005 | Pubmed ID: 16242331
Electron intraoperative treatment in patients with early-stage breast cancer: data update.
Expert review of anticancer therapy Apr, 2006 | Pubmed ID: 16613547
Image-guided radiotherapy and hypofractionation in lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer May, 2007 | Pubmed ID: 17457233
Partial breast irradiation: ready for routine?
Breast (Edinburgh, Scotland) Dec, 2007 | Pubmed ID: 17719226
The National Center for Oncological Hadron Therapy: status of the project and future clinical use of the facility.
Tumori , 2009 | Pubmed ID: 19579862
Integrated breast conservation and intraoperative radiation therapy.
Breast (Edinburgh, Scotland) Oct, 2009 | Pubmed ID: 19914553
Intraoperative radiation therapy: is it a standard now?
Breast (Edinburgh, Scotland) Oct, 2011 | Pubmed ID: 22015276
MRI for treatment planning: a necessity.
European journal of radiology Sep, 2012 | Pubmed ID: 23083551
Partial breast irradiation: targeting volume or breast molecular subtypes?
Breast (Edinburgh, Scotland) Aug, 2013 | Pubmed ID: 24074774
Tailoring radiotherapy according to cancer subtypes.
Breast (Edinburgh, Scotland) Aug, 2017 | Pubmed ID: 28673538
Radiation therapy for inflammatory breast cancer.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology Aug, 2018 | Pubmed ID: 29853159
Effects of L-DOPA Pretreatment on the Kinetics, Migration and Carbon Ion Radiation Response of T98G Cells.
Anticancer research Jan, 2019 | Pubmed ID: 30591448
Carbon Ion Radiotherapy in the Management of the Tumors of the Peripheral Nervous System.
Anticancer research Feb, 2019 | Pubmed ID: 30711975
Mould-based surface high-dose-rate brachytherapy for eyelid carcinoma.
Journal of contemporary brachytherapy Oct, 2019 | Pubmed ID: 31749853
High precision radiotherapy including intensity-modulated radiation therapy and pulsed-dose-rate brachytherapy for cervical cancer: a retrospective monoinstitutional study.
Journal of contemporary brachytherapy Dec, 2019 | Pubmed ID: 31969909
Machine Learning-Based Models for Prediction of Toxicity Outcomes in Radiotherapy.
Frontiers in oncology , 2020 | Pubmed ID: 32582539
High-dose-rate Brachytherapy as Adjuvant Local rEirradiation for Salvage Treatment of Recurrent breAst cancer (BALESTRA): a retrospective mono-institutional study.
Journal of contemporary brachytherapy Jun, 2020 | Pubmed ID: 32695191
Salvage high-dose-rate interstitial brachytherapy for perineal recurrence of prostate cancer after surgery and radiotherapy: a case report.
Journal of contemporary brachytherapy Oct, 2020 | Pubmed ID: 33299439
Intraoperative irradiation for early breast cancer (ELIOT): long-term recurrence and survival outcomes from a single-centre, randomised, phase 3 equivalence trial.
The Lancet. Oncology May, 2021 | Pubmed ID: 33845035
The T-N tract involvement as a new prognostic factor for PORT in locally advanced oral cavity tumors.
Oral diseases Apr, 2021 | Pubmed ID: 33893695
Adjuvant high-dose-rate interstitial brachytherapy for malignant peripheral nerve sheath tumor of the foot: a case report.
Journal of contemporary brachytherapy Jun, 2021 | Pubmed ID: 34122575
Partial breast irradiation with intraoperative radiotherapy in the ELIOT trial - Authors' reply.
The Lancet. Oncology Jul, 2021 | Pubmed ID: 34197758
Oligorecurrent Prostate Cancer and Stereotactic Body Radiotherapy: Where Are We Now? A Systematic Review and Meta-analysis of Prospective Studies.
European urology open science May, 2021 | Pubmed ID: 34337513
A Randomized Trial of Robotic Mastectomy Versus Open Surgery in Women With Breast Cancer or BrCA Mutation.
Annals of surgery Jul, 2022 | Pubmed ID: 34597010
Stereotactic radioablation for the treatment of ventricular tachycardia: preliminary data and insights from the STRA-MI-VT phase Ib/II study.
Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing Nov, 2021 | Pubmed ID: 34609691
Reproducibility of radiomic features in CT images of NSCLC patients: an integrative analysis on the impact of acquisition and reconstruction parameters.
European radiology experimental Jan, 2022 | Pubmed ID: 35075539
Single fraction ablative preoperative radiation treatment for early-stage breast cancer: the CRYSTAL study - a phase I/II clinical trial protocol.
BMC cancer Apr, 2022 | Pubmed ID: 35366825
Quality assurance for automatically generated contours with additional deep learning.
Insights into imaging Aug, 2022 | Pubmed ID: 35976491
Giuseppina Bonizzi*,1,
Maria Capra*,1,
Cristina Cassi1,
Giulio Taliento1,
Oriana Pala2,
Elham Sajjadi2,3,
Konstantinos Venetis2,3,
Mariia Ivanova2,
Massimo Monturano4,
Giuseppe Renne2,
Lorenzo Zattoni1,3,
Elena Guerini-Rocco2,3,
Giuseppe Viale2,3,
Roberto Orecchia5,
Nicola Fusco1,2,3
1Biobank for Translational and Digital Medicine Unit, IEO, European Institute of Oncology IRCCS,
2Division of Pathology, IEO, European Institute of Oncology IRCCS,
3Department of Oncology and Hemato-Oncology, University of Milan,
4Patient Safety & Risk Management Service, IEO, European Institute of Oncology IRCCS,
5Scientific Directorate, IEO, European Institute of Oncology IRCCS
SOBRE A JoVE
Copyright © 2024 MyJoVE Corporation. Todos os direitos reservados